Amy Wilson
Women's Health · Little Rock, ARNPI 1841380334
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,358 of the $2,873 with a category attached, or 82.0%. 11 manufacturers reported payments, led by Astellas Pharma US Inc at 34.6% of the total. 2025 is the largest year on record at $774, 2.4 times the $317 reported in 2021. Among women's health clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $26.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$995
- Sumitomo Pharma America, Inc.$645
- AbbVie$442
- Urovant Sciences Inc$250
- Medtronic$181
- 180 Medical, Inc.$148
- plus $213 from 5 others
What the payments were for
- Food & beverage$2,35882%
- Education$51618%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 21 | $995 |
| Sumitomo Pharma America, Inc. | 32 | $645 |
| AbbVie(2 entities) | 22 | $442 |
| Urovant Sciences Inc | 8 | $250 |
| Medtronic | 7 | $181 |
| 180 Medical, Inc. | 6 | $148 |
| Coloplast | 3 | $51 |
| Pfizer | 3 | $49 |
| Boston Scientific | 2 | $47 |
| Axonics, Inc. | 2 | $40 |
| Organon | 2 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,873 in reported general payments places this provider in the 90th percentile of 44 women's health providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 326 | $215,096 |
| MyrbetriqMirabegron | 311 | $188,878 |
| Estradiol | 237 | $13,749 |
| Methenamine Hippurate | 143 | $11,089 |
| PremarinEstrogens, Conjugated | 21 | $6,520 |
| OsphenaOspemifene | 17 | $4,182 |
| Fosfomycin Tromethamine | 19 | $3,323 |
| Trospium Chloride | 78 | $3,272 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 129 | $3,259 |
| Cephalexin | 220 | $2,268 |
| Desmopressin Acetate | 36 | $1,622 |
| Trimethoprim | 43 | $1,259 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 13 | $1,094 |
| Fluconazole | 105 | $1,058 |
| Clobetasol Propionate | 20 | $813 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $645 | $215,096326 claims |
| Astellas Pharma US IncMyrbetriq | $995 | $188,878311 claims |
| PfizerPremarin | $49 | $6,52021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 44 women's health providers in Arkansas.
Other women's health in Little Rock
- Becca AustinLittle Rock$2K
- Jeni WarriorLittle Rock$2K
- Laura KnarrLittle Rock$858
- Lindsey HuettLittle Rock$600
- Lori WilliamsLittle Rock$502
- Jessica SmithLittle Rock$401
- Amber MautnerLittle Rock$296
- Sarah HumphriesLittle Rock$274
- Tina ButlerLittle Rock$265
- Cassandra BrownLittle Rock$115
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.